Cargando…

COVID-19: Unanswered questions on immune response and pathogenesis

The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggi, Enrico, Canonica, Giorgio Walter, Moretta, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205667/
https://www.ncbi.nlm.nih.gov/pubmed/32389590
http://dx.doi.org/10.1016/j.jaci.2020.05.001
_version_ 1783530278575144960
author Maggi, Enrico
Canonica, Giorgio Walter
Moretta, Lorenzo
author_facet Maggi, Enrico
Canonica, Giorgio Walter
Moretta, Lorenzo
author_sort Maggi, Enrico
collection PubMed
description The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better understanding of the interactions between the virus and the host immune response and of the pathogenesis of infection is crucial to identify valid therapeutic tools to control virus entry, replication, and spread as well as to impair its lethal effects. On the basis of recent research progress of severe acute respiratory syndrome coronavirus 2 and the results on previous coronaviruses, in this contribution we underscore some of the main unsolved problems, mostly focusing on pathogenetic aspects and host immunity to the virus. On this basis, we also touch important aspects regarding the immune response in asymptomatic subjects, the immune evasion of severe acute respiratory syndrome coronavirus 2 in severe patients, and differences in disease severity by age and sex.
format Online
Article
Text
id pubmed-7205667
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
record_format MEDLINE/PubMed
spelling pubmed-72056672020-05-08 COVID-19: Unanswered questions on immune response and pathogenesis Maggi, Enrico Canonica, Giorgio Walter Moretta, Lorenzo J Allergy Clin Immunol Reviews and Feature Articles The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better understanding of the interactions between the virus and the host immune response and of the pathogenesis of infection is crucial to identify valid therapeutic tools to control virus entry, replication, and spread as well as to impair its lethal effects. On the basis of recent research progress of severe acute respiratory syndrome coronavirus 2 and the results on previous coronaviruses, in this contribution we underscore some of the main unsolved problems, mostly focusing on pathogenetic aspects and host immunity to the virus. On this basis, we also touch important aspects regarding the immune response in asymptomatic subjects, the immune evasion of severe acute respiratory syndrome coronavirus 2 in severe patients, and differences in disease severity by age and sex. The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020-07 2020-05-08 /pmc/articles/PMC7205667/ /pubmed/32389590 http://dx.doi.org/10.1016/j.jaci.2020.05.001 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Reviews and Feature Articles
Maggi, Enrico
Canonica, Giorgio Walter
Moretta, Lorenzo
COVID-19: Unanswered questions on immune response and pathogenesis
title COVID-19: Unanswered questions on immune response and pathogenesis
title_full COVID-19: Unanswered questions on immune response and pathogenesis
title_fullStr COVID-19: Unanswered questions on immune response and pathogenesis
title_full_unstemmed COVID-19: Unanswered questions on immune response and pathogenesis
title_short COVID-19: Unanswered questions on immune response and pathogenesis
title_sort covid-19: unanswered questions on immune response and pathogenesis
topic Reviews and Feature Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205667/
https://www.ncbi.nlm.nih.gov/pubmed/32389590
http://dx.doi.org/10.1016/j.jaci.2020.05.001
work_keys_str_mv AT maggienrico covid19unansweredquestionsonimmuneresponseandpathogenesis
AT canonicagiorgiowalter covid19unansweredquestionsonimmuneresponseandpathogenesis
AT morettalorenzo covid19unansweredquestionsonimmuneresponseandpathogenesis